| Revenues | | 174.61 | 202.31 | 252.41 | 238.49 |
| | 8.25 | - | - | - |
| Research and Development | | 8.25 | - | - | - |
| Depreciation and Amortization | | 191.56 | 285.82 | 167.31 | 161.74 |
| Operating Income/Loss | | -1,061.50 | -1,410.56 | 47.59 | 679.78 |
| Nonoperating Income/Loss | | -231.83 | -482.62 | 113.22 | 336.93 |
| Income/Loss From Equity Method Investments | | -2.17 | -2.07 | -1.71 | -0.90 |
| Income/Loss From Continuing Operations Before Tax | | -1,293.33 | -1,893.17 | 160.81 | 1,016.71 |
| Income Tax Expense/Benefit | | -30.93 | -183.39 | 37.68 | 208.50 |
| | -1,262.40 | -1,709.79 | 123.13 | 808.21 |
| Available To Common Stockholders, Basic | | -1,259.62 | -1,709.64 | 123.13 | 808.24 |
| | -2.78 | -0.14 | 0.01 | -0.03 |
| Redeemable Noncontrolling Interest | | -1.90 | - | - | - |
| Basic Average Shares | | 380.16 | 2.85 | 372.07 | 352.90 |
| Diluted Average Shares | | 380.16 | -94.91 | 470.13 | 440.91 |
| Basic Earnings Per Share | | -3.31 | -4.82 | 0.33 | 2.29 |
| Diluted Earnings Per Share | | -3.31 | -4.59 | 0.27 | 1.84 |